Serial #79409414
DEAD

Serial Number

79409414

Owner

Sandoz AG

Filing Date

Aug 6, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79409414 Trademark

Serial Number: 79409414

Serial #79409414 is a trademark filed by Sandoz AG on August 6, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Sandoz AG (3 trademarks)

Viaduktstrasse 3

Entity Type: 03

Trademark Details

Filing Date

August 6, 2024

Registration Date

Not Registered

Goods & Services

Anti-infectives for human use; anti-inflammatories for human use; antibacterial pharmaceutical preparations for human use; antibiotics for human use; antifungal preparations for human use; antivirals for human use; cardiovascular pharmaceutical preparations for human use; dermatological pharmaceutical preparations for human use; pharmaceutical preparations for human use for inhaling for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for human use acting on the central nervous system; pharmaceutical preparations and substances for human use for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for human use for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for human use, used in hematology and in tissue and organ transplantation; pharmaceutical preparations for human use for the prevention and treatment of eye diseases; pharmaceutical preparations for human use for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for human use for the prevention and treatment of diseases and disorders related to the immune system; pharmaceutical preparations for human use for the prevention and treatment of kidney diseases; pharmaceutical preparations for human use for the prevention and treatment of diabetes; pharmaceutical preparations for human use for the prevention and treatment of hypertension; pharmaceutical preparations for human use for the prevention and treatment of skin conditions; pharmaceutical preparations for human use, used in dermatology; pharmaceutical preparations for human use, used in urology; pharmaceutical preparations for human use, used in ophthalmology; pharmaceutical preparations for human use for the prevention and treatment of cancer and tumors; pharmaceutical preparations for human use for the prevention and treatment of allergies; pharmaceutical preparations for human use for the prevention and treatment of bone diseases; pharmaceutical preparations for human use for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 30, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 13, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 13, 2026 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 10, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 10, 2025 ABN2
REFUSAL PROCESSED BY IB
Mar 29, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 10, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 10, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 22, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 21, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 10, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 21, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 21, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 19, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 14, 2024 REPR